Yes, pharmacogenomics is a home run on straight forward cases, but the amazing thing is that straight forward cases are the most important for medicine. Drug-gene interactions are so unbelievably basic and require next to zero know how to correlate side effects to genes. My previous example of genomics not being lucid is in intelligence because we have zero idea what makes someone intelligent on a molecular level, which physicians could not care less about.
My final point is purely on practicality. Last I had heard, there are some hospital systems that have genome sequencing are down to tens of dollars and are done in under an hour or two. Isolating a single protein, looking at its expression, and assaying activity is not only the bane of every biochemists existence, it takes a significant amount of time and would have to be done for every single enzyme that we want to look at. We have to be practical in medicine and the most practical option for the foreseeable future, unless a CRISPR like breakthrough comes along, is going to be genome sequencing.
Now, what is going to be absolutely insane in the field of proteomics is when we can accurately predict a protein's structure and then make novel drugs to enhance or inhibit said protein. I can't remember how many amino acids it is before we're unable to predict the structure of a protein, but it's low and the current method to look at protein structure is stupid hard. Obnoxiously hard; I don't even want to talk about it but it's hard and you have to send your samples to a handful of locations. We use super computers at the moment to elucidate small proteins and usually they suck bad at doing it. If we were able to accurately predict structure and function of a novel protein with computer models, use CRISPR to insert the gene into a genome for said protein we are talking about increasing human life span in a logarithmic fashion.